Skip to content
Search for:
The Society
Board of Directors
Scientific Advisory Council
Contact
Events Calendar
Mentorship Program
Rare Disease Task Force
BOD Trainee Representatives
Awards & Grants
Lifetime Achievement Award
Young Investigator Award
Dr. Alan M. Gewirtz Memorial Scholarships
Award for Science Outreach or Patient Advocacy
Paper of the Year Awards
Poster Awards
Local & Regional Delivery Grants
Travel Grants
Science News
Recent Articles
President’s Pick and Perspective
Journal
Archive
Educational Video Library
OSWG Whitepapers
Support for Ukrainian Scientists
Job Board
Employer Profiles
Employer Registration / Login
Events
Annual Meetings
Past Annual Meetings
2024 Annual Meeting
2023 Annual Meeting
2022 Annual Meeting
2021 Annual Meeting
2020 Annual Meeting
Webinars
Events Calendar
2024 Event Registration
Membership
Become A Member or Renew Membership
Featured Members
Search for:
Re-Evaluating the Conventional Wisdom about Binding Assays
OTS
Aptamer
,
Reviews
May 15, 2020
SHARE
Post Views:
1,069
Wilson BD, Soh HT.
Trends Biochem Sci. 2020 May 10:S0968-0004(20)30108-0.
Pubmed
Previous
Next
Related articles
How to Develop and Prove High-Efficiency Selection of Ligands from Oligonucleotide Libraries: A Universal Framework for Aptamers and DNA-Encoded Small-Molecule Ligands
How to Develop and Prove High-Efficiency Selection of Ligands from Oligonucleotide Libraries: A Universal Framework for Aptamers and DNA-Encoded Small-Molecule Ligands
April 23rd, 2021
Recent progress in non-native nucleic acid modifications
Recent progress in non-native nucleic acid modifications
April 23rd, 2021
Targeted suicide gene therapy for liver cancer based on ribozyme-mediated RNA replacement through post-transcriptional regulation
Targeted suicide gene therapy for liver cancer based on ribozyme-mediated RNA replacement through post-transcriptional regulation
April 23rd, 2021
Hovlinc is a recently evolved class of ribozyme found in human lncRNA
Hovlinc is a recently evolved class of ribozyme found in human lncRNA
April 23rd, 2021
Immunotherapy for breast cancer using EpCAM aptamer tumor-targeted gene knockdown
Immunotherapy for breast cancer using EpCAM aptamer tumor-targeted gene knockdown
April 23rd, 2021
Antisense Technology: A Review.
Antisense Technology: A Review.
March 15th, 2021
Page load link
Go to Top